Literature DB >> 25635486

Management of pediatric septic shock. Progress through applied insight.

Brian P Kavanagh1, Anthony F Suffredini.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 25635486      PMCID： PMC4351584          DOI： 10.1164/rccm.201412-2299ED

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  11 in total

1.  Microarrays and molecular research: noise discovery?

Authors:  John P A Ioannidis
Journal:  Lancet       Date:  2005 Feb 5-11       Impact factor: 79.321

2.  Mortality after fluid bolus in African children with severe infection.

Authors:  Kathryn Maitland; Sarah Kiguli; Robert O Opoka; Charles Engoru; Peter Olupot-Olupot; Samuel O Akech; Richard Nyeko; George Mtove; Hugh Reyburn; Trudie Lang; Bernadette Brent; Jennifer A Evans; James K Tibenderana; Jane Crawley; Elizabeth C Russell; Michael Levin; Abdel G Babiker; Diana M Gibb
Journal:  N Engl J Med       Date:  2011-05-26       Impact factor: 91.245

3.  Projected impact of monoclonal anti-endotoxin antibody therapy.

Authors:  D W Bates; T H Lee
Journal:  Arch Intern Med       Date:  1994-06-13

4.  Lessons learned from clinical trials on monoclonal anti-endotoxin antibody.

Authors:  M H Weil
Journal:  Arch Intern Med       Date:  1994-06-13

5.  An evaluation of the diagnostic accuracy of the 1991 American College of Chest Physicians/Society of Critical Care Medicine and the 2001 Society of Critical Care Medicine/European Society of Intensive Care Medicine/American College of Chest Physicians/American Thoracic Society/Surgical Infection Society sepsis definition.

Authors:  Huifang Zhao; Stephen O Heard; Marie T Mullen; Sybil Crawford; Robert J Goldberg; Gyorgy Frendl; Craig M Lilly
Journal:  Crit Care Med       Date:  2012-06       Impact factor: 7.598

Review 6.  2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference.

Authors:  Mitchell M Levy; Mitchell P Fink; John C Marshall; Edward Abraham; Derek Angus; Deborah Cook; Jonathan Cohen; Steven M Opal; Jean-Louis Vincent; Graham Ramsay
Journal:  Intensive Care Med       Date:  2003-03-28       Impact factor: 17.440

7.  Treatment of septic shock with human monoclonal antibody HA-1A. A randomized, double-blind, placebo-controlled trial. CHESS Trial Study Group.

Authors:  R V McCloskey; R C Straube; C Sanders; S M Smith; C R Smith
Journal:  Ann Intern Med       Date:  1994-07-01       Impact factor: 25.391

8.  Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. The HA-1A Sepsis Study Group.

Authors:  E J Ziegler; C J Fisher; C L Sprung; R C Straube; J C Sadoff; G E Foulke; C H Wortel; M P Fink; R P Dellinger; N N Teng
Journal:  N Engl J Med       Date:  1991-02-14       Impact factor: 91.245

9.  Simplified severe sepsis protocol: a randomized controlled trial of modified early goal-directed therapy in Zambia.

Authors:  Ben Andrews; Levy Muchemwa; Paul Kelly; Shabir Lakhi; Douglas C Heimburger; Gordon R Bernard
Journal:  Crit Care Med       Date:  2014-11       Impact factor: 7.598

10.  Identification of pediatric septic shock subclasses based on genome-wide expression profiling.

Authors:  Hector R Wong; Natalie Cvijanovich; Richard Lin; Geoffrey L Allen; Neal J Thomas; Douglas F Willson; Robert J Freishtat; Nick Anas; Keith Meyer; Paul A Checchia; Marie Monaco; Kelli Odom; Thomas P Shanley
Journal:  BMC Med       Date:  2009-07-22       Impact factor: 8.775
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.